Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA VENUS REMEDIES ABBOTT INDIA/
VENUS REMEDIES
 
P/E (TTM) x 53.1 15.0 354.2% View Chart
P/BV x 19.3 0.9 2,045.1% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 ABBOTT INDIA   VENUS REMEDIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
VENUS REMEDIES
Mar-23
ABBOTT INDIA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs22,482379 5,933.4%   
Low Rs16,156145 11,142.1%   
Sales per share (Unadj.) Rs2,517.0415.5 605.8%  
Earnings per share (Unadj.) Rs446.819.9 2,248.5%  
Cash flow per share (Unadj.) Rs479.744.0 1,089.6%  
Dividends per share (Unadj.) Rs325.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs1,480.5344.3 430.0%  
Shares outstanding (eoy) m21.2513.37 158.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.70.6 1,217.6%   
Avg P/E ratio x43.213.2 328.1%  
P/CF ratio (eoy) x40.35.9 677.0%  
Price / Book Value ratio x13.00.8 1,715.5%  
Dividend payout %72.70-   
Avg Mkt Cap Rs m410,5133,501 11,724.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,636570 987.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,4875,555 962.9%  
Other income Rs m1,543103 1,494.8%   
Total revenues Rs m55,0305,658 972.6%   
Gross profit Rs m12,055602 2,002.4%  
Depreciation Rs m700323 216.6%   
Interest Rs m1603 5,438.8%   
Profit before tax Rs m12,738379 3,358.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244114 2,854.5%   
Profit after tax Rs m9,494266 3,573.8%  
Gross profit margin %22.510.8 208.0%  
Effective tax rate %25.530.0 85.0%   
Net profit margin %17.84.8 371.2%  
BALANCE SHEET DATA
Current assets Rs m30,2513,230 936.7%   
Current liabilities Rs m12,060826 1,460.6%   
Net working cap to sales %34.043.3 78.6%  
Current ratio x2.53.9 64.1%  
Inventory Days Days8737 235.2%  
Debtors Days Days2504 0.4%  
Net fixed assets Rs m15,1352,781 544.2%   
Share capital Rs m213134 159.0%   
"Free" reserves Rs m31,2484,470 699.1%   
Net worth Rs m31,4604,603 683.4%   
Long term debt Rs m0387 0.0%   
Total assets Rs m45,3866,011 755.1%  
Interest coverage x80.7130.0 62.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.9 127.5%   
Return on assets %21.34.5 476.0%  
Return on equity %30.25.8 522.9%  
Return on capital %41.07.7 535.2%  
Exports to sales %0.40-   
Imports to sales %10.80-   
Exports (fob) Rs m221NA-   
Imports (cif) Rs m5,765NA-   
Fx inflow Rs m3100-   
Fx outflow Rs m5,8180-   
Net fx Rs m-5,5080-   
CASH FLOW
From Operations Rs m8,934366 2,439.2%  
From Investments Rs m-1,477-508 290.6%  
From Financial Activity Rs m-6,387-6 112,450.7%  
Net Cashflow Rs m1,070-220 -485.2%  

Share Holding

Indian Promoters % 0.0 41.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 1.6 561.0%  
FIIs % 0.2 1.6 11.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 58.2 42.9%  
Shareholders   72,252 19,560 369.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs VENUS REMEDIES Share Price Performance

Period Abbott India VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 0.67% 6.34% 0.88%
1-Month -3.13% -7.16% -4.09%
1-Year 34.31% 106.70% 59.00%
3-Year CAGR 25.47% 7.98% 18.97%
5-Year CAGR 31.27% 56.79% 19.20%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.